Literature DB >> 9579575

Increased invasiveness of MUC1 and cDNA-transfected human gastric cancer MKN74 cells.

T Suwa1, Y Hinoda, Y Makiguchi, T Takahashi, F Itoh, M Adachi, M Hareyama, K Imai.   

Abstract

MUC1 mucin is an anti-adhesion molecule expressed in a wide variety of tumors. To examine whether MUC1 mucin is involved in tumor invasion, we have prepared MUC1 transfectants using the human gastric cancer cell line MKN74 and performed an in vivo tumor assay by transplanting these into nude mice. Tumor weight at 71 days after s.c. injection of transfectants was measured, showing that the in vivo growth of MUC1 transfectants was increased compared to that of mock transfectants. Furthermore, MUC1-transfectant tumors invaded into the muscle layer, whereas mock-transfectant tumors did not. In vitro invasion, adhesion to extracellular matrix components and phagokinetic track motility were then evaluated to analyze the mechanisms for the in vivo invasiveness of the transfectants. MUC1 transfectants exhibited an increased in vitro invasiveness, decreased binding to laminin, fibronectin, type I collogen and type IV collagen and increased motility. These effects of MUC1 mucin over-expression in MKN74 cells were abolished by the treatment of transfectants with an inhibitor of O-glycan biosynthesis, benzyl-alpha-GalNAc. Our data suggest that MUC1 mucin could be related to the increased invasive ability of MKN74 cells, whereas O-glycan might play an essential role.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579575     DOI: 10.1002/(sici)1097-0215(19980504)76:3<377::aid-ijc15>3.0.co;2-8

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.

Authors:  A Lugli; I Zlobec; K Baker; P Minoo; L Tornillo; L Terracciano; J R Jass
Journal:  J Clin Pathol       Date:  2006-06-30       Impact factor: 3.411

Review 2.  MUC1 (CD227): a multi-tasked molecule.

Authors:  Vasso Apostolopoulos; Lily Stojanovska; Sharron E Gargosky
Journal:  Cell Mol Life Sci       Date:  2015-08-21       Impact factor: 9.261

3.  Absence of correlation of MUC1 expression to malignant behavior of renal cell carcinoma in experimental systems.

Authors:  K Denda-Nagai; K Fujita; M Fujime; S Nakatsugawa; T Ishigaki; T Irimura
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Aberrant expression of CD227 is correlated with tumor characteristics and invasiveness of breast carcinoma.

Authors:  Ya-Wen Wang; Duan-Bo Shi; Ya-Min Liu; Yan-Lin Sun; Xu Chen; Shuai Xiang; Qiang Fu; Jun-Min Wei; Peng Gao
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-01       Impact factor: 4.553

5.  Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design.

Authors:  Antonio Evidente; Artem S Kireev; Aaron R Jenkins; Anntherese E Romero; Wim F A Steelant; Severine Van Slambrouck; Alexander Kornienko
Journal:  Planta Med       Date:  2009-02-23       Impact factor: 3.352

6.  MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion.

Authors:  Jingchun Gao; Matthew J McConnell; Bin Yu; Jiannong Li; Justin M Balko; Esther P Black; Joseph O Johnson; Mark C Lloyd; Soner Altiok; Eric B Haura
Journal:  Int J Oncol       Date:  2009-08       Impact factor: 5.650

7.  Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence.

Authors:  T Hamada; S Matsukita; M Goto; S Kitajima; S K Batra; T Irimura; K Sueyoshi; K Sugihara; S Yonezawa
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

8.  The expression of human FUT1 in HT-29/M3 colon cancer cells instructs the glycosylation of MUC1 and MUC5AC apomucins.

Authors:  Anna López-Ferrer; Carme de Bolós
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

Review 9.  MUC1 in carcinoma-host interactions.

Authors:  K Denda-Nagai; T Irimura
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 3.009

Review 10.  MUC1, the renaissance molecule.

Authors:  S J Gendler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.